APA Alıntı

Heeke, S., Benzaquen, J., Long-Mira, E., Audelan, B., Lespinet, V., Bordone, O., . . . Hofman, P. (2019). In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients. Cancers (Basel).

Chicago Stili Alıntı

Heeke, Simon, et al. "In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients." Cancers (Basel) 2019.

MLA Alıntı

Heeke, Simon, et al. "In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients." Cancers (Basel) 2019.